IP Library Granted Patent US 9,534,050
Granted Patent B2
US 9,534,050 · App. 14/514,493 · Granted Jan 3, 2017

Antibodies to tumor endothelial marker 7R

Inventors: Hossein Borghaei (King of Prussia, PA); Louis M. Weiner (Washington, DC)
Assignee: Institute for Cancer Research
C07K16/28A61K47/48561A61K51/1027A61K51/1063C07K16/3046A61K2039/505C07K2317/33C07K2317/622C07K2317/73C07K2317/77C07K2317/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,534,050
App. No.
14/514,493
Granted
Jan 3, 2017
Kind
B2
Abstract

Antibodies that specifically bind to an epitope on the extracellular domain of TEM7R are provided. Nucleic acids encoding such antibodies and cells capable of expressing such antibodies are also provided. The antibodies may be used in methods for treating tumors and for inhibiting angiogenesis in tumors.

Claims (24)

1. An isolated antibody, comprising a heavy chain variable region having the amino acid sequence of SEQ ID NO: 9 and a light chain variable region, wherein the antibody specifically binds to an epitope on the extracellular domain of TEM7R.

2. The antibody of claim 1 , wherein the light chain variable region comprises the amino acid sequence of SEQ ID NO: 10.

3. The antibody of claim 1 , wherein the antibody is a monoclonal antibody.

4. The antibody of claim 1 , wherein the antibody comprises a single chain Fv.

5. The antibody of claim 4 , wherein the single chain Fv comprises the amino acid sequence of SEQ ID NO: 11.

6. The antibody of claim 1 , wherein the antibody is a chimeric antibody.

7. The antibody of claim 1 , wherein the antibody is conjugated to a chemotherapeutic agent.

8. The antibody of claim 1 , wherein the antibody is conjugated to a detectable label.

9. The antibody of claim 1 , wherein the TEM7R is human TEM7R.

10. The antibody of claim 1 , wherein the TEM7R is mouse TEM7R.

11. A composition, comprising the antibody of claim 1 and a pharmaceutically acceptable carrier.

12. A composition, comprising the antibody of claim 7 and a pharmaceutically acceptable carrier.

13. An isolated antibody, comprising a. light chain variable region having the amino acid sequence of SEQ ID NO, 10and a heavy chain variable region, wherein the antibody specifically binds to an epitope on the extracellular domain of TEM7R.

14. The antibody of claim 13 , wherein the heavy chain variable region comprises the amino acid sequence of SEQ ID NO: 9.

15. The antibody of claim 13 , wherein the antibody is a monoclonal antibody.

16. The antibody of claim 13 , wherein the antibody comprises a single chain Fv.

17. The antibody of claim 16 , wherein the single chain Fv comprises the amino acid sequence of SEQ ID NO: 11.

18. The antibody of claim 13 , wherein the antibody is a chimeric antibody.

19. The antibody of claim 13 , wherein the antibody is conjugated to a chemotherapeutic agent.

20. The antibody of claim 13 , wherein the antibody is conjugated to a detectable label.

21. The antibody of claim 13 , wherein the TEM7R is human TEM7R.

22. The antibody of claim 13 , wherein the TEM7R is mouse TEM7R.

23. A composition, comprising the antibody of claim 13 and a pharmaceutically acceptable carrier.

24. A composition, comprising the antibody of claim 20 and a pharmaceutically acceptable carrier.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 31, 2019
From: FOX CHASE CANCER CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 048198/0953 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 14, 2014
From: BORGHAEI, HOSSEIN; WEINER, LOUIS M.
To: INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER
Reel/Frame 034170/0866 →
Continuity (3)
Continuation 13697024
Provisional Application 61333554 · May 11, 2010
Related Publication 20150064190A1 · Mar 5, 2015